Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.97 | 6695378 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
4.02 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.35 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.34 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.45 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
5.08 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.16 | 16197459 16206674 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.39 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.80 | 18412241 16357521 16651633 16436596 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.22 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.48 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
6.23 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.39 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.34 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
4.04 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
7.05 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.48 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
6.23 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.47 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 14991402 9211117 10589399 9125849 17551590 9224671 16925845 9142499 9664655 8800419 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
7.05 | 18357618 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.54 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.40 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.94 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.27 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
8.42 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
8.42 | 17312396 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.64 | 18412241 16357521 16651633 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.49 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
6.23 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.11 | 9664655 14991402 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.62 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.33 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.53 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.45 | 17551590 15992940 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
4.36 | 17379185 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.97 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.25 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.13 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.45 | 12679006 17217047 16823087 19642359 17301526 15748426 17649720 19035177 16140955 17339181 19225113 17107899 16891316 17361223 19029980 9834237 16935935 16766008 17294898 19075265 17506722 17368321 16331271 17712046 16788101 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.65 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.63 | 6695378 16271038 17703301 16019985 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.28 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.81 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.80 | 10838139 10767621 18041768 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.93 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.99 | 16752155 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
7.05 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
5.19 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.32 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.60 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
5.16 | 16707424 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.45 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.35 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
6.30 | 17160924 16003739 16651423 |
OMIM:163500 |
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2 |
marker/mechanism |
|
| |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
7.05 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.46 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.33 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.59 | 15976015 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.21 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.68 | 16723453 |
MESH:D012162 |
Retinal Degeneration |
marker/mechanism |
|
| 16123450 |
MESH:D012174 |
Retinitis Pigmentosa |
marker/mechanism |
|
| |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.71 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.79 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
6.05 | 15790496 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.40 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.29 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.50 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.18 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.68 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.73 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.44 | 16287080 |